McKesson Subsidiary Secures New $2.25 Billion Senior Secured Term Loan Facility
Summary
McKesson's subsidiary obtained a new $2.25 billion senior secured term loan due 2032, providing substantial capital for corporate transactions and general purposes.
Key Events
-
New $2.25 Billion Term Loan Facility
McKesson Medical-Surgical Top Holdings, a subsidiary, entered into an amendment to its Credit Agreement to establish a new $2.25 billion senior secured Term B Loan Facility due 2032.
-
Loan Terms and Security
The loan bears interest at Adjusted Term SOFR Rate plus 2.25% per annum and is secured by substantially all tangible and intangible assets of the borrower and its U.S. guarantors.
-
Use of Proceeds
Proceeds will be used to fund corporate transactions, including the repayment of indebtedness to McKesson Parent, and for general corporate purposes.
-
Follows Recent Capital Raises
This new facility follows other significant debt facilities secured in April 2026, indicating ongoing capital restructuring.
Analysis
McKesson Medical-Surgical Top Holdings, a subsidiary of McKesson Corp, has secured a new $2.25 billion senior secured Term B Loan Facility due 2032. This loan, bearing interest at Adjusted Term SOFR Rate plus 2.25%, is secured by substantially all assets of the borrower and its U.S. guarantors. The proceeds will be used to fund corporate transactions, including the repayment of indebtedness to McKesson Parent, and for general corporate purposes. This is a significant capital raise that enhances the company's financial flexibility and supports ongoing corporate restructuring efforts, following other recent large debt facilities.
At the time of this filing, MCK was trading at $790.21 on NYSE in the Trade & Services sector, with a market capitalization of approximately $94.6B. The 52-week trading range was $637.00 to $999.00. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.